Search clinical trials for: Intravenous levetiracetam

Total 6633 results

UCB Pharma

Completed

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Epilepsy, Partial
UCB Pharma

Completed

Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Generalized Convulsive Epilepsy
Tanta University

Unknown

Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus

Comparison | the Efficacy of Levetireacetam | Phenytoin | Management of Pediatric Status Epilepticus

Egypt
University of Colorado, Denver

Recruiting

Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia

Schizophrenia

United States
UCB Pharma

Completed

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

Epilepsy, Partial

Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Thailand
Loyola University

Unknown

Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?

Seizures | Traumatic Brain Injury

United States
Berkshire Health Systems
UCB Pharma

Completed

Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) (pmdd)

Premenstrual Dysphoric Disorder

United States
UCB Pharma

Completed

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Epilepsy
UCB Pharma

Completed

Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

Epilepsy
University of California, San Francisco
UCB Pharma

Completed

Levetiracetam for Treatment of Pain Associated With Fibromyalgia

Fibromyalgia

United States
UCB Pharma

Completed

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Epilepsy

Spain
VA Office of Research and Development

Active, not recruiting

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Schizophrenia

United States
NYU Langone Health
National Institutes of Health (NIH)

Completed

Levetiracetam in Early Psychosis

Schizophrenia | Psychosis | Schizo Affective Disorder | Schizophreniform

United States
Indiana University

Terminated

Seizure Prophylaxis in Aneurysm Repair

Seizures | Intracranial Aneurysms

United States
UCB Pharma

Completed

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Epilepsy

Poland, United States, Mexico, Russian Federation
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Non-Fasting Conditions

Healthy

United States
UCB Pharma

Completed

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Idiopathic Parkinson Disease
UCB Pharma

Completed

Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

Epilepsy
Walter Reed National Military Medical Center

Not yet recruiting

Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) (LAPSE)

Alzheimer Disease

United States
Beth Israel Deaconess Medical Center

Recruiting

Treating Hyperexcitability in AD With Levetiracetam (LeAD)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer Dementia | Dementia of Alzheimer Type

United States
University of Oxford
UCB Pharma; Oxford University Hospitals NHS Trust; Oxford Health NHS Foundation... and other collaborators

Completed

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD)

Epilepsy | Alzheimer Disease

United Kingdom
UCB Pharma

Completed

A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

Epilepsy, Partial
Technische Universität Dresden
UCB Pharma GmbH

Completed

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease (LeLeDys)

Parkinson's Disease

Germany
University of Florida

Completed

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

Brain Neoplasms | Brain Cancer | Brain Tumors | Seizure | Cancer of the Brain | Cancer of Brain

United States
UCB Japan Co. Ltd.

Completed

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Epilepsy | Generalized Tonic-Clonic Seizures

China, Japan
Children's Hospital of Fudan University
Second Affiliated Hospital of Wenzhou Medical University; Guangzhou Women and... and other collaborators

Terminated

Levetiracetam Treatment of Neonatal Seizures

Neonatal Seizures

China
Assistance Publique - Hôpitaux de Paris

Completed

Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (SAMU-KEPPRA)

Status; Epilepticus, Tonic-clonic

France
Duke University
UCB Pharma

Completed

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Progressive Muscular Atrophy

United States
UCB Pharma

Completed

Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
UCB Pharma

Completed

Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Epilepsy

France, United States, Belgium, Mexico, Turkey, Germany
UCB Pharma

Completed

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Epilepsy | Generalized Tonic-clonic Seizures

Japan
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

Epilepsy | Partial Seizures
Beijing Pins Medical Co., Ltd

Unknown

Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)

Epileptic Encephalopathy

China
UCB Pharma

Completed

A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

Human Volunteers

China
Rennes University Hospital
UCB Pharma

Terminated

Prevention of Post-traumatic Seizures With Levetiracetam (TRACK)

Epilepsy, Post-Traumatic

France
1st Hospital of Social Security Services
UCB Pharma

Unknown

Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease

Levodopa Induced Dyskinesia

Greece
Yale University
Stanley Medical Research Institute

Completed

Levetiracetam in the Management of Bipolar Depression

Bipolar Depression

United States
UCB Japan Co. Ltd.

Completed

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Epilepsy | Generalized Tonic-clonic Seizures

Japan
UCB Pharma

Completed

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Human Volunteers

China
Brigham and Women's Hospital

Completed

Add on Lacosamide Versus High Dose Monotherapy

Epilepsy

United States
Xiangya Hospital of Central South University

Recruiting

Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy

Epilepsy | Alzheimer Disease 3

China
Dhaka Medical College

Enrolling by invitation

The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus

Status Epilepticus

Bangladesh
Tata Memorial Centre

Not yet recruiting

Short Versus Long-term Levetiracetam in Brain Tumors (LIBRA)

Seizures | Brain Tumors | Antiepileptics | Levetiracetam
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.

Healthy

United States
Pavel Klein
Medstar Health Research Institute

Completed

Levetiracetam to Prevent Post-Traumatic Epilepsy

Epilepsy | Post-traumatic Epilepsy

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

Healthy

United States
UCB Pharma

Completed

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

Epilepsy, Partial

United States, France, United Kingdom, Germany, Belgium, Mexico, Poland, Romania, Canada, Brazil, Russian Federation, Argentina, Hungary, Italy, Czechia

Search clinical trials for: Intravenous levetiracetam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations